Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wellsmith is a digital health company that provides a comprehensive care management platform designed to help patients manage chronic conditions such as type 2 diabetes and heart failure. The company's technology integrates data from connected medical devices, such as glucose monitors and scales, with a mobile application to provide real-time coaching and clinical insights. By connecting patients, caregivers, and clinicians, Wellsmith aims to improve adherence to treatment plans and reduce the cost of care for health systems. The company was notably partnered with Cone Health before its assets were acquired by Voluntis in 2021, which was subsequently integrated into Aptar Pharma's digital health division.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wellsmith.